期刊论文详细信息
Frontiers in Public Health | |
Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US | |
Xintian Wang1  Hongchao Li1  Aixia Ma1  Ye Shang1  Yingcheng Wang1  Lan Yang1  Mingjun Rui1  | |
[1] School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China;Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China; | |
关键词: small-cell lung cancer; cost-effectiveness; atezolizumab; chemotherapy; extensive stage; | |
DOI : 10.3389/fpubh.2021.650392 | |
来源: Frontiers | |